Key points of the international Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas （2023）

VernacularTitle:《2023年国际胰腺病协会京都指南：胰腺导管内乳头状黏液性肿瘤的管理》意见要点
Author: Jiasu LI ¹ ; Hongxin SUN ¹ ; Zhaoshen LI ¹
Author Information

1. Department of Gastroenterology， Digestive Endoscopy Center， Changhai Hospital， Navy Medical University， Shanghai 200433， China
Publication Type:Journal Article
Keywords: Pancreatic Intraductal Neoplasms; Diagnosis; Surveillance; Guidelines
From: Journal of Clinical Hepatology 2024;40(3):478-482
CountryChina
Language:Chinese
Abstract: Recently， the International Association of Pancreatology published a revised edition of the guidelines for the management of intraductal papillary mucinous neoplasm （IPMN） of the pancreas. The guidelines mainly focus on five topics， i.e.， revision of “high-risk stigmata” and “worrisome features”， surveillance of unresected IPMN， surveillance after resection of IPMN， revision of pathological aspects， and research on molecular markers in cyst fluid， in order to provide the best evidence-based reference for clinical practice. This article makes an excerpt of the key points in the guidelines.